钱多多股票论坛

trader1688.com
 FAQ FAQ RSS

支持168: Amazon Ebay Amazon(Canada)
Half


Post new topic Reply to topic  [ 544 Posts ]  Go to page Previous  1 ... 33, 34, 35, 36, 37
Author Message
 Post subject: Re: 盘前个股动态2016
PostPosted: 9/21/17 22:14 
Offline 模拟帐户

Joined: 8/8/10 22:40
Posts: 1554
SCANX Gapping down

Gapping down
In reaction to disappointing earnings/guidance:

SCHL -5.1%, MLHR -2.7%, DPS -0.7%, (lowers 2017 EPS guidance by $0.03 per share to reflect anticipated impact from supplier default)
Select metals/mining stocks trading lower:

HMY -2.1%, VALE -1.8%, CLF -1.5%, MT -1.2%, GDX -1.2%, ABX -1.1%, AU -1%, IAG -1%, RIO -0.9%, GOLD -0.8%, GG -0.8%, AUY -0.7%, NEM -0.6%, GLD -0.6%, BHP -0.5%
Other news:

RWLK -8.8% (files for $15 mln ordinary share offering)
JUNO -3.8% (announces $225 mln share offering)
IOVA -3.5% (prices offering of 7,692,308 shares of common stock at $6.50 per share)
CRTO -2.4% (Gotham City Research confirmed plans to release second portion of CRTO series)
NVDA -1.7% (extending late move lower on reports that Tesla is wokring with AMD for an AI self-sdriving chip)
USG -1.2% (continued strength -- gypsum/wallboard related names were notably higher on anticipated price increase)
CMG -1.1% (pulling back as yesterday's queso related optimism fades)
XLRN -1.1% (prices offering of 5,405,406 shares of common stock at $37.00 per share)
RIG -0.8% (Chevron terminates driling contract for elected to exercise its contractual option to terminate the drilling contract for the ultra-deepwater drillship Discoverer Clear Leader, effective November 2017, prior to its expiration in October 2018)
SCG -0.7% (served with a subpoena issued by the United States Attorney's Office for the District of South Carolina seeking documents relating to the Company's new nuclear project at V.C. Summer Nuclear Station)
Analyst comments:

JKS -3.2% (initiated with a Sell at Axiom Capital)
ERIC -1.8% (downgraded to SEll from Hold at Carnegie)
TEX -1% (downgraded to Hold from Buy at Deutsche Bank)
HBI -0.8% (downgraded to Neutral from Buy at Instinet)

Gapping up
In reaction to strong earnings/guidance:

N/A.
M&A news:

CCC +62.1% (to be acquired by Kuraray for $21.50 per share)
CRH +1.9% (acquires Ash Grove Cement for $3.5 bln)
Other news:

ITUS +11.4% (renews research agreement for continued development of Cchek and enters into an exclusive option agreement to license intellectual property covering a proprietary CAR-T technology w/ The Wistar Institute)
BCRX +9.9% (announces FDA approval of a sNDA for RAPIVAB)
AMPH +6.8% (received FDA approval of its ANDA for sodium bicarbonate injection 8.4% in 50 mL Luer-Jet Prefilled Syringe System)
ABUS +6.6% (continued strength)
PRQR +5.5% (presents data 'in a relevant disease model, establishing proof of concept for its novel and proprietary Axiomer RNA editing platform technology)
TPRE +4.5% (to join S&P SmallCap 600)
APC +4.3% (Anadarko Petroleum announces $2.5 bln share-repurchase program; co also reaffirms the guidance it had previously provided for the deepwater Gulf of Mexico, DJ and Delaware basin assets )
FOLD +4.2% (confirms being granted orphan drug designation by the FDA for ATB200/AT2221)
GVP +3.6% (GSE Systems, Inc. acquires Absolute Consulting, Inc., a provider of technical consulting and staffing solutions to the global nuclear power industry, for $8.75 mln in cash )
APRN +3.3% higher after Albertsons announced the acquisition of Plated, a premier meal kit service)
KND +2.7% (sees $20 mln pre-tax hit to Q3 earnings due to Hurricanes Harvey and Irma)
AERI +2.6% (confirms FDA Advisory Committe meeting scheduled for October 13 to review its NDA for Rhopressa for the treatment of patients with open-angle glaucoma or ocular hypertension)
AMD +1.5% (extending late move higher on reports that Tesla is wokring with AMD for an AI self-sdriving chip)
MDXG +1.3% (responds to 'deceptive short seller articles' )


 
 Profile  
Reply to topic 
 Post subject: Re: 盘前个股动态2016
PostPosted: 9/25/17 00:40 
Offline 模拟帐户

Joined: 8/8/10 22:40
Posts: 1554
This week's top 20 % gainers
Healthcare: ALNY (113.8 +49.32%), QDEL (43.1 +20.36%), LJPC (37.21 +18.2%), AXON (24.99 +17.1%), MCRB (16.75 +14.18%)
Materials: CCC (21.4 +60.9%)
Industrials: OA (132.64 +20.54%), AJRD (33.89 +19.63%), MTOR (26.4 +16.92%), CUB (51.6 +16.35%), HTZ (23.55 +14.49%)
Information Technology: SSNI (16.18 +24.46%)
Energy: SDRL (0.39 +64.84%), PGH (0.94 +50.62%), FMSA (4.19 +21.45%), CRC (10.18 +19.62%), EMES (9.17 +15.64%), TGS (20 +14.88%), CVE (10.28 +13.72%)
Consumer Staples: REV (19.9 +23.99%)
This week's top 20 % losers
Healthcare: ICPT (61.59 -35.09%), SUPN (39 -20.49%), KND (6.25 -13.79%), MNKD (1.98 -13.54%), IONS (51.32 -13.35%), NLNK (10.99 -13.26%), AERI (50.95 -12.61%)
Materials: MUX (2.06 -20.16%), SBGL (4.69 -15.04%), CMP (60.1 -13.71%), HMY (1.86 -13.08%), KGC (4.25 -11.83%)
Industrials: RUN (5.59 -16.82%), HDSN (7.94 -13.32%)
Consumer Discretionary: BBBY (22.51 -21.49%), PIR (4.15 -20.19%), MMYT (28.45 -16.2%), RCII (10.8 -13.88%)
Information Technology: SNCR (9.2 -42.89%), GOGO (12.45 -11.76%)


 
 Profile  
Reply to topic 
 Post subject: Re: 盘前个股动态2016
PostPosted: 9/26/17 22:35 
Offline 模拟帐户

Joined: 8/8/10 22:40
Posts: 1554
Gapping down
In reaction to disappointing earnings/guidance:

FTK -2.8%, (Flotek Industries provides Q3 update - estimates revs will be approx $5.0 mln less than previously expected and incremental costs will increase by less than $1.0 mln; activity delays are largely expected to be made up for in Q4)
DRI -2.6%, INFO -0.5%, CIFS -0.5%
Other news:

AXON -70.6% (announces negative topline results of Intepirdine Phase 3 MINDSET Trial)
GNCA -59.5% ( announces strategic shift to immuno-oncology/development of neoantigen cancer vaccines; corporate restructuring and exploration of strategic alternatives for GEN-003 )
KDMN -21.1% (announces proposed public offering of common stock and warrants)
TXMD -10.1% (prices offering of 12.4 mln shares of common stock at $5.65 per share)
QEP -7.7% (closes Pinedale divestiture; reduced 2017 oil production guidance to midpoint of 19.75 MMbbl, natural gas production to midpoint of 167.5 Bcf and NGL production to midpoint of 5.5 MMbbl )
SBRA -6.4% (prices offering of 16 mln shares of common stock at $21.00 per share)
CSGP -1.8% (files mixed securities shelf offering; commenced public offering of $750.0 million of common stock)
Analyst comments:

AFL -1.7% (downgraded to Sell from Neutral at Citigroup)
LEA -1.3% (downgraded to Neutral from Buy at Buckingham Research)
CAKE -1% (downgraded to Neutral from Outperform at Wedbush)
SHAK -0.9% (downgraded to Neutral from Outperform at Wedbush)
TCO -0.8% (downgraded to Neutral from Overweight at JP Morgan)
INT -0.7% (downgraded to Underperform from Neutral at BofA/Merrill)
JPM -0.5% (downgraded to Hold from Buy at Deutsche Bank)
08:19 SCANX Gapping up

Gapping up
In reaction to strong earnings/guidance:

ASNA +17.5%, SNX +9.9%, RHT +4.8%
M&A news:

ACTA +38.8% (Actua to sell its three majority-owned businesses for an aggregate of $549 million in cash; intends to distribute substantially all net proceeds to Actua stockholders)
Other news:

IZEA +32.2% (reports Q3 contract wins including a seven-figure contract renewal with a Fortune 500 financial services company for custom content and influencer marketing services)
CDXC +16% (announces that initial results of its second human clinical study of NIAGEN)
GHL +12.5% ( plans leveraged recapitalization with major share repurchase; to borrow $300 mln and shortly launch contingent tender offer to repurchase up to 9 mln shares at $17/share )
PRQR +10.1% ( announces 'positive' top-line results from Phase 1b safety and tolerability clinical trial of QR-010, a novel investigational RNA therapeutic in subjects with cystic fibrosis )
ITUS +6.5% (continued strength)
NDRO +5.7% (announced a special cash distribution)
CBIO +4.3% (FDA has granted orphan drug designation for CB 2679d/ISU304 for treatment of hemophilia b)
SFLY +3.8% (confirmed integration with the Apple Photos app for macOS High Sierra )
XLRN +3.1% (10% owner Celgene (CELG) discloses the purchase of 745,592 shares at $37 per share)
AMPH +3% (receives FDA approval for Neostigmine Methylsulfate Injection)
NVDA +2.9% (reports of deal to supply GPU hardware to Chinese tech giants including BABA, BIDU and TCEHY)
BEAT +1.4% (Aeterna Zentaris appointed Jeffrey Whitnell as Interim CFO effective today - served as Vice-President, Finance & Controller of Lifewatch Services - was acquired by BioTelemetry)
APRI +1.2% (files for 3,311,752 share common stock offering by holders and separately filed to withdraw Registration Statement on Form S-3 filed August 22, 2017)
BABA +1% (to increase stake in Cainiao Network to 51% with $807 mln investment)
CLDR +0.8% (Cloudera proposes to sell 3 mln shares of common stock and selling stockholders to sell 9 mln shares)
WDC +0.7% (reports that KKR is urging Apple to agree to terms of Toshiba deal that includes WDC in jv role)
Analyst comments:

DISCA +2% (upgraded to Neutral from Sell at UBS)
RH +2% (upgraded to Buy from Hold at Deutsche Bank)
LB +1.8% (upgraded to Overweight from Neutral at Atlantic Equities)
TMO +1.7% (resumed on the Conviction Buy List at Goldman)
GGP +1.3% (upgraded to Overweight from Neutra


 
 Profile  
Reply to topic 
 Post subject: Re: 盘前个股动态2016
PostPosted: 9/27/17 09:05 
Offline 模拟帐户

Joined: 8/8/10 22:40
Posts: 1554
Gapping up
In reaction to strong earnings/guidance:

MU +5.5%, LNDC +4.8%, FWP +4.8%, HUBS +1.9%
M&A news:

TMUS +1.9% (to acquire the remaining interest of Iowa Wireless from Aureon)
Other news:

AVGR +194.7% (confirms CE Marking approval for treating in-stent restenosis with the Pantheris Lumivascular atherectomy system), IMNP +85% (announces prelim results from the first six subjects enrolled in its ongoing, open-label phase 2 study of bertilimumab), MARK +38.5% (awarded a seven-figure contract by one of the largest state-owned enterprises in China to provide a facial and object recognition technology to a Shanghai municipal health agency), CALI +14.7% (entered into a Debt Exchange Agreement ), ZSAN +10.1% (received official written notification of USPTO regarding patent application 15/438,455 'Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines' ), WYY +7% (announced an award of Option Year 2 task order modification for cellular wireless managed services by United States Immigration and Customs Enforcement for approximately $9.3 million), CASC +5.4% (FDA granted orphan drug designation to tucatinib for the treatment of HER2-positive metastatic colorectal cancer), KEM +4.1% (KEMET will replace Astoria Financial in the S&P SmallCap 600), EDIT +3.7% (EMA granted Orphan Medicinal Product designation to EDIT-101, a pre-clinical, CRISPR-based medicinal product to treat Leber Congenital Amaurosis type 10), SIX +3.4% (Six Flags will replace PAREXEL in the S&P MidCap 400), TWTR +1.7% (Twitter to revise character limit among other items), RH +1.6% (Chairman/CEO discloses the purchase of 13,959 shares - transaction dates today), CTLT +1.5% (prices offering of 6,395,000 shares of common stock at $39.10 per share), AMGN +1.1% (Amgen and Simcere Pharmaceutical Group execute exclusive agreement to co-develop and commercialize four biosimilars in China; specific financial terms of the agreement were not disclosed), STL +1% (Sterling Bancorp will replace Oil States International in the S&P MidCap 400)
Analyst comments:

CDNA +7.8% (upgraded to Outperform from Mkt Perform at Raymond James)
ZEAL +5.6% (initiated with a Buy at Goldman)
PSO +5% (upgraded to Outperform from Underperform at Exane BNP Paribas)
LITE +3.9% (upgraded to Buy from Neutral at MKM Partners)
VSLR +3.1% (initiated with a Buy at Guggenheim)
KORS +2.4% (upgraded to Buy from Hold at Canaccord Genuity)
TEF +2.1% (upgraded to Buy from Hold at Berenberg)
RBS +2% (upgraded to Buy from Hold at Jefferie)
DRI +1.3% (upgraded to Outperform from Neutral at Robert W. Baird)
BABA +1.1% (resumed with a Outperform at Wells Fargo),
IDU +1% (initiated with a Outperform at Wells Fargo)
EBAY +0.9% (resumed with a Outperform at Wells Fargo)
JD +0.8% (initiated with a Outperform at Wells Fargo)
AMZN +0.8% (resumed with a Outperform at Wells Fargo)
NFLX +0.7% (initiated with a Outperform at Wells Fargo)

Gapping down
In reaction to disappointing earnings/guidance:

KRNT -20.4%, NKE -3.5%, ARCW -2.1%, (also announces initial results from strategic operating review), ATU -1.3%
Other news:

ITCI -7.2% (commences an underwritten public offering of $150 mln of shares of its common stock)
ASND -2.3% (commences public offering of $125 mln of American Depositary Shares, each of which represents one ordinary share of Ascendis )
FINL -1.6% (following NKE earnings)
SONC -1% (Krebs report of security breach)
Analyst comments:

SPWR -3.3% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
TRVG -1.9% (downgraded to Neutral from Overweight at JP Morgan)
TTS -2.7% (downgraded to Neutral from Overweight at Piper Jaffray)
WBA -0.7% (downgraded to Mkt Perform from Outperform at Raymond James)
CLXT -2.4% (downgraded to Neutral from Buy at Citigroup)


 
 Profile  
Reply to topic 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 544 Posts ]  Go to page Previous  1 ... 33, 34, 35, 36, 37

Home 


Who is online

Users browsing this forum: Googlebot and 1 guest


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum
You cannot post attachments in this forum

Search for:

Batch Generator
Hutong9 SizzlingStock GaoFamily  Hearty  TT  股通 财籽 GrusInvest E.T. Yahoo Google msn 大千 未名 外汇牛人邦 CNFinance 华人 investern optionpain YangCai 司空金融网


This site is mainly for stock market discussion, it does not provide any investment advice. It is not suggested to rely on posts here for investment decision.
本网站主要作为股市讨论用途,并不提供任何投资建议。请不要将本站内容作为投资依据,否则风险自负。

钱多多股票论坛 - Trader1688.com© Powered by phpBB © 2002, 2006 phpBB Group